Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk

Maria Stella de Biase,Florian Massip,Tzu-Ting Wei,Federico M. Giorgi,Rory Stark,Amanda Stone,Amy Gladwell,Martin O’Reilly,Daniel Schütte,Ines de Santiago,Kerstin B. Meyer,Florian Markowetz,Bruce A. J. Ponder,Robert C. Rintoul,Roland F. Schwarz

DOI: https://doi.org/10.1186/s13073-024-01317-4

IF: 15.266

2024-04-10

Genome Medicine

Abstract:Lung cancer is the leading cause of cancer-related death in the world. In contrast to many other cancers, a direct connection to modifiable lifestyle risk in the form of tobacco smoke has long been established. More than 50% of all smoking-related lung cancers occur in former smokers, 40% of which occur more than 15 years after smoking cessation. Despite extensive research, the molecular processes for persistent lung cancer risk remain unclear. We thus set out to examine whether risk stratification in the clinic and in the general population can be improved upon by the addition of genetic data and to explore the mechanisms of the persisting risk in former smokers.

genetics & heredity

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the impact of smoking on nasal epithelial gene expression and, through these changes, to reveal immune dysfunctions related to lung cancer risk. Specifically, the research aims to:

1. **Evaluate smoking - related gene expression changes and their reversibility after smoking cessation**: Researchers analyzed the nasal epithelial tissue transcriptome data of individuals with different smoking statuses (including healthy volunteers and clinical patients) to determine the gene expression changes caused by smoking and explore the recovery of these changes after smoking cessation.

2. **Explore the mechanisms of persistent lung cancer risk in long - term smokers**: More than 50% of smoking - related lung cancers occur in people who have already quit smoking, and 40% of these cases still occur 15 years after smoking cessation. Researchers hope to reveal the molecular mechanisms of persistently high lung cancer risk by analyzing the gene expression patterns of these individuals.

3. **Develop a non - invasive lung cancer risk classifier**: Based on the transcriptome data of nasal epithelial tissue, researchers attempt to develop a non - invasive tool that can predict lung cancer risk, in order to conduct more effective risk stratification in clinical and general populations.

4. **Correlate genetic variations with smoking - damage responses**: By integrating genotype data, researchers hope to reveal the genetic basis for differences in smoking - damage responses among individuals, especially the associations with known lung cancer risk loci (GWAS), thereby providing evidence for the causal role of genetic variations in immune and interferon - related pathways.

Through these research objectives, the paper aims to provide new insights into understanding the lung cancer risk caused by smoking and to provide a scientific basis for improving early detection and risk stratification strategies for lung cancer.